Stayble Therapeutics AB (publ) (STO:STABL)

Market Cap	13.19M -45.2%
Revenue (ttm)	-17.00K
Net Income	-10.75M
EPS	n/a
Shares Out	64.36M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	505,055
Open	0.2200
Previous Close	0.2150
Day's Range	0.1955 - 0.2230
52-Week Range	0.0274 - 0.6460
Beta	-0.88
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 4, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: STABL

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 5, 2026

Data Sources Report a data error